Monitoring antiangiogenesis of bevacizumab in zebrafish

Jing Zhang,1,2,* Beili Gao,1,* Wenchao Zhang,1 Zijun Qian,1 Yi Xiang1 1Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Institute of Respiratory Diseases, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of China; 2Respiratory Department...

書誌詳細
出版年:	Drug Design, Development and Therapy
主要な著者:	Zhang J, Gao BL, Zhang WC, Qian ZJ, Xiang Y
フォーマット:	論文
言語:	英語
出版事項:	Dove Medical Press 2018-08-01
主題:	Zebrafish Bevacizumab anti-angiogenesis
オンライン･アクセス:	https://www.dovepress.com/monitoring-antiangiogenesis-of-bevacizumab-in-zebrafish-peer-reviewed-article-DDDT

類似資料

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab
著者:: Neel Patel, 等
出版事項: (2017-05-01)

The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea
著者:: Luiz F.M. Barros, 等
出版事項: (2007-09-01)

A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
著者:: Soysal D., 等
出版事項: (2014-12-01)

Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer
著者:: Ananaya Datta-Mitra, 等
出版事項: (2014-01-01)

The effects of genistein as antiinflammatory and antiangiogenesis in primary endometriosis cell culture
著者:: Sutrisno Sutrisno, 等
出版事項: (2014-12-01)

Bevacizumab in Pediatric Neuro-Oncology
著者:: Jacob Silverman, 等
出版事項: (2025-10-01)

Anti-angiogenic and antitumor effects of anlotinib combined with bevacizumab for colorectal cancer
著者:: Min Yan, 等
出版事項: (2024-03-01)

Clinical case use bevacizumab for patient with metastatic ovarian cancer
著者:: M. R. Oganyan, 等
出版事項: (2014-07-01)

A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants
著者:: Gustavo Maluf, 等
出版事項: (2019-10-01)

Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization
著者:: Ulrike Lessiak, 等
出版事項: (2023-10-01)

Application of Zebrafish as a Model for Anti-Cancer Activity Evaluation and Toxicity Testing of Natural Products
著者:: Yifan Shen, 等
出版事項: (2023-06-01)

The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab
著者:: Haiyan Jia, 等
出版事項: (2021-10-01)

Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma
著者:: Seung Won Choi, 等
出版事項: (2018-05-01)

Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer
著者:: Mohsin Hamid, 等
出版事項: (2018-05-01)

Bevacizumab in ovarian cancer therapy: current advances, clinical challenges, and emerging strategies
著者:: Mingyue Zhang, 等
出版事項: (2025-05-01)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
著者:: Evita Maria Lindholm, 等
出版事項: (2019-10-01)

Use of Bevacizumab in the Treatment of Corneal Neovascularization
著者:: Tuba Çelik, 等
出版事項: (2015-01-01)

Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer: A randomized, double-blind, phase 3 trial
著者:: Yuankai Shi, 等
出版事項: (2025-07-01)

Profiles of Endoglin and Vascular Endothelial Growth Factor Based on Staging and Histological Grading of Colorectal Cancer and Their Relationship with Bevacizumab Therapy
著者:: Rahmawati Minhajat, 等
出版事項: (2021-05-01)

Mvda is required for zebrafish early development
著者:: Wenghong Wong, 等
出版事項: (2021-05-01)

NIR-IIb fluorescence antiangiogenesis copper nano-reaper for enhanced synergistic cancer therapy
著者:: Wenling Li, 等
出版事項: (2024-02-01)

Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model
著者:: Hatem Abuohashish, 等
出版事項: (2023-05-01)

Fotocoagulación panretinal y bevacizumab intravítreo en el tratamiento de la retinopatía diabética proliferativa activa
著者:: Arianna Hernández Pérez, 等

Opportunities and Challenges for Successful Use of Bevacizumab in Pediatrics
著者:: Amy eBarone, 等
出版事項: (2013-04-01)

Pro-Angiogenic Effects of Chalcone Derivatives in Zebrafish Embryos in Vivo
著者:: Yau-Hung Chen, 等
出版事項: (2015-07-01)

Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
著者:: Xueting Wan, 等
出版事項: (2021-10-01)

Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies
著者:: Xiao Han, 等
出版事項: (2023-07-01)

Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
著者:: Giammaria Fiorentini, 等
出版事項: (2022-03-01)

Cambio de grosor macular central con la administración de Bevacizumab Intravítreo
著者:: Martin Barrios Fernández, 等
出版事項: (2017-07-01)

Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
著者:: Girolamo Ranieri, 等
出版事項: (2021-02-01)

The correlation between fluoride-induced bone damage and reduced DLAV formation in Zebrafish Larvae
著者:: Ailin Lan, 等
出版事項: (2024-12-01)

Bevacizumab increases the incidence of cardiovascular events in patients with metastatic breast or colorectal cancer
著者:: Ioannis Kapelakis, 等
出版事項: (2017-05-01)

Short-term intraocular pressure changes after intravitreal bevacizumab injection
著者:: Ali Dehghani, 等
出版事項: (2014-08-01)

Short-term intraocular pressure changes after intravitreal bevacizumab injection
著者:: Ali Dehghani, 等
出版事項: (2014-06-01)

Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs
著者:: Joji Nakayama, 等
出版事項: (2020-05-01)

The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study
著者:: Ping-Chih Hsu, 等
出版事項: (2020-10-01)

Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives
著者:: McClung EC, 等
出版事項: (2016-03-01)

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
著者:: Sylvie Négrier, 等
出版事項: (2017-08-01)

Marine Compound Catunaregin Inhibits Angiogenesis through the Modulation of Phosphorylation of Akt and eNOS in vivo and in vitro
著者:: Jun-Xiu Liu, 等
出版事項: (2014-05-01)

Promising Phytoconstituents in Antiangiogenesis Drug Development
著者:: Ibrahim M. Abu-Reidah, 等
出版事項: (2024-09-01)